Abstract
Co-infection of Tuberculosis (caused by Mycobacterium tuberculosis bacteria) and HIV (caused by Human Immunodeficiency virus) remains a global burden on public health system and poses particular diagnostic and therapeutic challenges. Due to co-infection, HIV speeds up the progression from latent to active TB and TB bacteria also accelerates the progress of HIV infection which ultimately leads to serious condition in individuals. In this research work, we formulate a six compartment mathematical model on the HIV-TB co-infection dynamics incorporating Macrophage (active and infected), T-cell (active and infected), Virus, and Bacteria population. Moreover, we explore the accelerating effect of both pathogens on each other in mathematical perceptive. Our analytical study reveals the conditions for the persistence of co-infection and also validates the stability criteria of equilibrium points for the disease. We also evaluate the disease-free condition using next generation method, expressed by the basic reproductive ratio (\(R_0\)). Moreover, our analytical and numerical simulations manifest the influence of certain key parameters on the threats posed by the impact of HIV-TB co-infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization, Global tuberculosis report 2017, Available: http://www.who.int/en/news-room/fact-sheets/detail/tuberculosis
A. Pawlowski, M. Jansson, M. Skld, M.E. Rottenberg, G. Killenius, Tuberculosis and HIV co-infection. PLoS Pathog. 8(2), e1002464 (2012)
R.M. Houben, P.J. Dodd, The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 13(10), e1002152 (2016)
P.L. Liu, J.L. Flynn, Understanding latent tuberculosis: a moving target. J. Immunol. 185(1), 15–22 (2010)
UNAIDS (2017) report, Available: https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics
G.A.C. Blood, Human immunodeficiency virus (HIV). Transfus. Med. Hemotherapy 43(3), 203 (2016)
C.C. Chang, M. Crane, J. Zhou, J.J. Post, B.A. Cameron, A.R. Lloyd, A. Jaworowski, M.A. French, S.R. Lewin, HIV and co-infections. Immunol. Rev. 254(1), 114–142 (2013)
World Health Organization (WHO), Global tuberculosis report 2017, http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf. Accessed 10 Jan 2017
K.C. McCullough, A. Summerfield, Basic concepts of immune response and defense development. ILAR J 46(3), 230–240 (2005)
V. Trouplin, N. Boucherit, L. Gorvel, F. Conti, G. Mottola, E. Ghigo, Bone marrow-derived macrophage production. J. Vis. Exp.: JoVE 81 (2013)
R.N. La Motte-Mohs, E. Herer, J.C. Ziga-Pflcker, Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105(4), 1431—1439 (2005)
M.S. Blumenreich, The White Blood Cell and Differential Count, Clinical Methods: The History, Physical, and Laboratory Examinations [Internet], 3rd edn. (Butterworths, Boston, 1990)
L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, C. Gerard, CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384(6605), 179 (1996)
B. Lee, M. Sharron, L.J. Montaner, D. Weissman, R.W. Doms, Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. 96(9), 5215–5220 (1999)
A.N. Chatterjee, P.K. Roy, Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection. Int. J. Control 85(2), 220–237 (2012)
P.K. Roy, A.N. Chatterjee, T-cell proliferation in a mathematical model of CTL activity through HIV-1 infection. Proc. World Congr. Eng. I, 615–620 (2010)
S. Gordon, Pattern recognition receptors: doubling up for the innate immune response. Cell 111(7), 927–930 (2002)
D. Kirschner, Dynamics of Co-infection withM. tuberculosisand HIV-1. Theor. Popul. Biol. 55(1), 94–109 (1999)
C.K. Kwan, J.D. Ernst, HIV and tuberculosis: a deadly human syndemic. Clin. Microbiol. Rev. 24(2), 351–376 (2011)
S. Pathak, T. Wentzel-Larsen, B. Åsjö, Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages. Infect. Immun. 78(9), 4022–4032 (2010)
E.M. Shankar, R. Vignesh, R. EllegAard, M. Barathan, Y.K. Chong, M.K. Bador, D.V. Rukumani, N.S. Sabet, A. Kamarulzaman, V. Velu, M. Larsson, HIV Mycobacterium tuberculosis co-infection: a danger-couple model of disease pathogenesis. Pathog. Dis. 70(2), 110–118 (2014)
D. Wolday, B. Tegbaru, A. Kassu, T. Messele, R. Coutinho, D. van Baarle, F. Miedema, Expression of chemokine receptors CCR5 and CXCR4 on CD4\(+\) T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients. JAIDS J. Acquir. Immune Defic. Syndr. 39(3) 265–271 (2005)
P.A. Selwyn, D. Hartel, V.A. Lewis, E.E. Schoenbaum, S.H. Vermund, R.S. Klein, A.T. Walker, G.H. Friedland, A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320(9), 545–550 (1989)
C.R. Diedrich, J.L. Flynn, HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?. Infect. Immun. 79(4), 1407–1417 (2011)
R. Naresh, D. Sharma, A. Tripathi, Modelling the effect of tuberculosis on the spread of HIV infection in a population with density-dependent birth and death rate. Math. Comput. Model. 50(7–8), 1154–1166 (2009)
G. Bolarin, I.U. Omatola, A mathematical analysis of HIV/TB Co-infection model. Appl. Math. 6(4), 65–72(2016)
C.J. Silva, D.F. Torres, A TB-HIV/AIDS coinfection model and optimal control treatment (2015). arXiv:1501.03322
A. Mallela, S. Lenhart, N.K. Vaidya, HIVTB co-infection treatment: modeling and optimal control theory perspectives. J. Comput. Appl. Math. 307 143–161 (2016)
T.D. Awoke, M.K. Semu, Optimal control strategy for TB-HIV/AIDS Co-infection model in the presence of behaviour modification. Processes 6(5), 48 (2018)
L.I.W. Roeger, Z. Feng, C. Castillo-Chavez, Modeling TB and HIV co-infections. Math. Biosci. Eng. 6(4), 815–837 (2009)
G. Magombedze, W. Garira, E. Mwenje, In-vivo mathematical study of co-infection dynamics of HIV-1 and Mycobacterium tuberculosis. J. Biol. Syst. 16(03), 357–394 (2008)
A. Hurwitz, On the conditions under which an equation has only roots with negative real parts. Sel. Pap. Math. Trends Control. Theory 65, 273–284 (1964)
G.J. Abiodun, N. Marcus, K.O. Okosun, P.J.Witbooi, A model for control of HIV/AIDS with parental care. Int. J. Biomath. 6(02), 1350006 (2013)
A.K. Roy, P.K. Roy, E. Grigorieva, Mathematical insights on psoriasis regulation: role of Th 1 and Th 2 cells. Math. Biosci. Eng. 15(3), 717–738 (2018)
T. Shiri, W. Garira, S.D. Musekwa, A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters. MBE 2, 811–832 (2005)
S. Marino, D.E. Kirschner, The human immune response to Mycobacterium tuberculosis in lung and lymph node. J. Theor. Biol. 227(4), 463–486 (2004)
Acknowledgements
Suman Dolai was the recipient of JUNIOR RESEARCH FELLOWSHIP (CSIR), File No-09/096(0904)/2017-EMR-I. Amit Kumar Roy acknowledges DST-PURSE PROJECT (Phase-II), Government of India, Department of Mathematics, Jadavpur University, Kolkata-700032, India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
17.6 Appendix
17.6 Appendix
\( A = -\sum a_{ii} \)
\( B= \sum a_{ii}a_{jj}-\sum a_{ij}a_{ji}\)
\( C= \sum a_{ij}a_{ji}a_{kk} -\sum a_{ii}a_{jj}a_{kk}-\sum a_{ij}a_{jk}a_{ki}\)
\(D=\sum a_{ii}a_{jj}a_{kk}a_{ll}+\sum a_{ij}a_{ji}a_{ki}a_{ll}{+}\sum a_{ij}a_{ji}a_{kl}a_{lk}{-}\sum a_{ij}a_{ji}a_{kk}a_{ll}{-}\sum a_{ij}a_{jk}a_{kl}a_{li}\)
\(E= \sum a_{ij}a_{ji}a_{kk}a_{ll}a_{mm}-\sum a_{ii}a_{jj}a_{kk}a_{ll}a_{mm}-\sum a_{ij}a_{jk}a_{kl}a_{li}a_{mm}-\sum a_{ij}a_{jk}a_{ki}a_{ll}a_{mm}-\sum a_{ij}a_{ji}a_{kl}a_{lk}a_{mm} +\sum a_{ij}a_{jk}a_{kl}a_{lm}a_{mi}\)
\( F= \sum a_{ii}a_{jj}a_{kk}a_{ll}a_{mm}a_{nn}{+}\sum a_{ij}a_{jk}a_{kl}a_{lm}a_{mi}a_{nn}{+}\sum a_{ij}a_{ji}a_{kl}a_{lk}a_{mm}a_{nn}{+}\sum a_{ij}a_{jk}a_{ki}a_{lm}a_{mn}a_{nl}\) \(-\sum a_{ij}a_{ji}a_{kk}a_{ll}a_{mm}a_{nn}-\sum a_{ij}a_{ji}a_{kl}a_{lm}a_{mk}a_{nn}\)
Here, A, B, C, D, E, and F follows a rule: \(i\ne j \ne k\ne l\ne m \ne n\). In \(a_{ij}\), if \(i=1\), then j can go to 6 or 5. Following same rule for k, l, m, n. Similarly, 2 can go 5 or 6. 3 can go 5. 4 can go 5 or 3. 5 can go 2 or 3 or 4 or 6 and 6 can go 1 or 2 or 5. In \(a_{ij}a_{ji}\), let \(i=1\) then j can go 5 or 6. But, \(a_{15}a_{51}\) does not exist because 5 cannot go to 1.
Let \( B= \sum a_{ii}a_{jj}-\sum a_{ij}a_{ji}\)
By above rule \(B=\sum _{i=1}^5a_{ii}\sum _{j=i+1}^6 a_{jj}-\{a_{16}a_{61}+a_{26}a_{62}+a_{25}a_{52}+a_{35}a_{53}+a_{45}a_{54}+a_{56}a_{65}\}\).
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dolai, S., Roy, A.K., Roy, P.K. (2020). Mathematical Study on Human Cells Interaction Dynamics for HIV-TB Co-infection. In: Manchanda, P., Lozi, R., Siddiqi, A. (eds) Mathematical Modelling, Optimization, Analytic and Numerical Solutions. Industrial and Applied Mathematics. Springer, Singapore. https://doi.org/10.1007/978-981-15-0928-5_17
Download citation
DOI: https://doi.org/10.1007/978-981-15-0928-5_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0927-8
Online ISBN: 978-981-15-0928-5
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)